NCT05091073
- Conditions
- Dyslipidemias, Elevated Cholesterol, Established Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD Risk, +6 more
- Locations
-
- Novo Nordisk Investigational Site Berlin, Germany
Clinical trial condition
Explore clinical trials studying Established Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD Risk. Study availability and eligibility vary by location and protocol.
NCT05091073